{"gene":"GNAL","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2012,"finding":"GNAL (encoding Gαolf) loss-of-function mutations (nonsense p.Ser293* and missense p.Val137Met, plus 6 additional mutations) cause primary torsion dystonia; impaired function of several mutants was demonstrated by BRET assays measuring Gαolf coupling activity.","method":"Exome sequencing, Sanger sequencing, bioluminescence resonance energy transfer (BRET) functional assay","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — BRET functional assay across multiple mutants, replicated across two families plus 6 additional mutations, published in high-impact peer-reviewed journal","pmids":["23222958"],"is_preprint":false},{"year":2014,"finding":"GNAL missense mutations p.Gly213Ser and p.Ala353Thr impair Gαolf coupling to dopamine D1 receptors, as shown by BRET assay; variant p.Ala311Thr behaved like wild-type in the BRET assay (negative result for pathogenicity).","method":"Sanger sequencing, bioluminescence resonance energy transfer (BRET) assay measuring Gαolf–D1 receptor coupling","journal":"JAMA neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct functional BRET assay of mutant vs wild-type coupling, with built-in negative control (p.Ala311Thr), replicates approach of PMID:23222958","pmids":["24535567"],"is_preprint":false},{"year":2005,"finding":"GNAL encodes two isoforms of Gαolf (a canonical and a longer alternative-first-exon isoform) that display different CNS expression patterns and both functionally couple to the dopamine D1 receptor when heterologously expressed in Sf9 cells; CpG islands near both first exons are differentially methylated, consistent with genomic imprinting.","method":"Identification of alternative transcript by 5′ RACE; heterologous expression in Sf9 cells for functional coupling; bisulfite/methylation analysis of CpG islands","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — heterologous expression functional coupling + methylation analysis, single lab, two orthogonal methods","pmids":["16044173"],"is_preprint":false},{"year":2017,"finding":"Gαolf (encoded by GNAL) is enriched in striatal projection neurons where it mediates dopamine and adenosine signaling via the cAMP pathway; heterozygous Gnal knockout mice show altered self-grooming, motor coordination, spine morphology, and phospho-CaMKIIβ in the striatum, and develop dystonia-like movements after oxotremorine (cholinergic agonist) administration—prevented by M1 muscarinic antagonists and replicated by intrastriatal (but not cerebellar) oxotremorine infusion.","method":"Heterozygous Gnal+/- knockout mouse model; behavioral testing; EEG; pharmacological challenge (oxotremorine, telenzepine, pirenzepine, trihexyphenidyl, mecamylamine); intrastriatal vs. cerebellar drug infusion; striatal spine morphology and biochemistry","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO model with multiple orthogonal behavioral, pharmacological, and anatomical readouts; striatal specificity established by site-specific infusion","pmids":["28546310"],"is_preprint":false},{"year":2016,"finding":"A novel GNAL variant p.F133L causes partial loss of Gαolf function: the mutant shows elevated basal BRET signal and severely diminished amplitude of dopamine-stimulated response, indicating impaired receptor-signal transduction.","method":"Sanger sequencing; BRET assay of Gαolf signaling in response to dopamine","journal":"Journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional BRET assay with quantitative readout, single lab, one method","pmids":["26810727"],"is_preprint":false},{"year":2019,"finding":"Gαolf deficiency (Gnal+/- mice) intensifies responses to D2 receptor blockade (haloperidol), causing increased catalepsy, persistent DNA breaks, decreased cAMP-dependent histone H3 phosphorylation (Ser10), and increased cell death in the striatum; aged Gnal+/- mice show increased global DNA methylation, increased euchromatin, and dendritic structural abnormalities.","method":"Gnal+/- mouse model; haloperidol administration; behavioral testing (catalepsy); γH2AX/comet assay for DNA breaks; immunohistochemistry for H3 phospho-Ser10; global methylation assay; chromatin fractionation; dendritic morphology analysis","journal":"Experimental neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical and histological readouts in genetic KO model, single lab","pmids":["31034808"],"is_preprint":false},{"year":2024,"finding":"Loss of Gαolf (GNAL) in the striatum disrupts the A2AR/D2R–adenylyl cyclase–cAMP cascade: A2AR total levels increase, adenylyl cyclase 5 (AC5) decreases, D2R levels decrease along with its regulatory proteins RGS9-2, spinophilin, Gβ5, and β-arrestin2; D2R-mediated inhibitory effect on cholinergic interneurons is significantly attenuated in GNAL+/- rat striatum.","method":"Biochemical analysis (western blot) of receptor and signaling protein levels in GNAL+/- rat striatum; whole-cell patch-clamp electrophysiology of striatal cholinergic interneurons","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — combined biochemical and electrophysiological approach in genetic rat model, multiple protein targets, single lab","pmids":["38182074"],"is_preprint":false},{"year":2024,"finding":"Conditional striatal knockout of Gnal in mice produces overt dystonia-like motor phenotypes (hindlimb clasping, torticollis, motor incoordination) and increases excitability of striatal spiny projection neurons, establishing a direct causal link between striatal Gαolf loss and both behavioral dystonia and cellular hyperexcitability.","method":"Conditional Gnal fl/fl knockout mouse model; Cre delivery via genetics or AAV; motor behavioral testing; ex vivo whole-cell patch-clamp electrophysiology of striatal spiny projection neurons","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined cellular electrophysiological phenotype, preprint not yet peer-reviewed","pmids":["39253490"],"is_preprint":true},{"year":2025,"finding":"Cell-type-specific conditional deletion of Gnal confirms Gαolf critically regulates adenylyl cyclase 5 (AC5) coupling to D1 and A2A receptors in striatal projection neurons: loss in D1-SPNs causes nocturnal hyperactivity and motor deficits; loss in A2A-SPNs causes striking spontaneous hyperactivity unresponsive to psychostimulants or A2A agonist, and paradoxically reduced by caffeine, revealing distinct functional roles of Gαolf downstream of each receptor class.","method":"Cell-type-specific conditional Gnal knockout mice (D1-SPN-specific and A2A-SPN-specific); motor behavioral testing; pharmacological challenges (cocaine, D-amphetamine, methylphenidate, KW6002, caffeine); biochemical analysis of AC5 coupling","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific genetic dissection with multiple behavioral and pharmacological readouts, peer-reviewed publication","pmids":["40902679"],"is_preprint":false},{"year":2000,"finding":"The human GNAL gene spans >80 kb on chromosome 18p11, contains 12 coding exons, and is expressed as a single ~5.9 kb transcript in the brain; 5′ RACE identified an additional transcription initiation site; 3′ RACE confirmed functionality of the downstream polyadenylation signal.","method":"Genomic sequencing; 5′ and 3′ RACE; Northern blot","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct experimental characterization of gene structure by RACE and sequencing, single lab","pmids":["11032382"],"is_preprint":false}],"current_model":"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons and olfactory epithelium that forms a heterotrimeric complex (with β2γ7) to mediate stimulatory coupling of dopamine D1 and adenosine A2A receptors to adenylyl cyclase 5 (AC5), thereby driving cAMP production; loss-of-function mutations impair this receptor–AC coupling (demonstrated by BRET and electrophysiology), disrupt D2R/A2AR signaling cascades and striatal spiny projection neuron excitability, and cause isolated dystonia (DYT25), with cell-type-specific deletion experiments showing distinct roles of Gαolf downstream of D1-SPNs (motor coordination) versus A2A-SPNs (locomotor tone)."},"narrative":{"mechanistic_narrative":"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons that couples dopamine and adenosine receptors to the adenylyl cyclase–cAMP pathway [PMID:28546310]. Gαolf functionally couples to the dopamine D1 receptor and transduces dopamine-stimulated signaling, an activity quantifiable by BRET [PMID:24535567, PMID:26810727]. In the striatum, Gαolf loss disrupts the A2AR/D2R–adenylyl cyclase 5 (AC5) cascade: A2AR levels rise while AC5, D2R, and its regulatory partners RGS9-2, spinophilin, G β5, and β-arrestin2 fall, and D2R-mediated inhibition of cholinergic interneurons is attenuated [PMID:38182074]. Cell-type-specific deletion establishes that Gαolf regulates AC5 coupling to both D1 and A2A receptors, with loss in D1-SPNs producing motor deficits and loss in A2A-SPNs producing spontaneous hyperactivity, revealing distinct roles downstream of each receptor class [PMID:40902679]. Loss-of-function mutations in GNAL cause isolated/primary torsion dystonia (DYT25), and striatal or conditional Gnal deletion reproduces dystonia-like motor phenotypes alongside increased spiny projection neuron excitability [PMID:23222958, PMID:39253490]. The gene produces alternative transcripts from differentially methylated first-exon promoters consistent with genomic imprinting [PMID:16044173].","teleology":[{"year":2000,"claim":"Establishing the genomic architecture of human GNAL was a prerequisite for interpreting later disease variants and isoform usage.","evidence":"Genomic sequencing, 5′/3′ RACE, and Northern blot of the chromosome 18p11 locus","pmids":["11032382"],"confidence":"Medium","gaps":["Does not address protein function","Did not resolve the tissue distribution of distinct isoforms"]},{"year":2005,"claim":"Identifying two Gαolf isoforms with differential CNS expression and demonstrating both couple to the D1 receptor connected gene structure to signaling output and raised imprinting as a regulatory layer.","evidence":"5′ RACE, heterologous expression in Sf9 cells for D1 coupling, and bisulfite methylation analysis","pmids":["16044173"],"confidence":"Medium","gaps":["Imprinting inferred from methylation, not allele-specific expression in vivo","Functional distinction between isoforms not resolved","Single-lab heterologous system"]},{"year":2012,"claim":"Linking GNAL loss-of-function mutations to primary torsion dystonia and showing impaired coupling activity established GNAL as a dystonia gene with a measurable molecular defect.","evidence":"Exome/Sanger sequencing in two families plus additional mutations, with BRET coupling assays of mutants","pmids":["23222958"],"confidence":"High","gaps":["Did not define which receptor–effector step each mutation disrupts in neurons","No structural mechanism of how mutations impair coupling"]},{"year":2014,"claim":"Demonstrating that specific missense mutants impair Gαolf–D1 receptor coupling while a control variant behaved as wild-type provided a functional assay to discriminate pathogenic from benign variants.","evidence":"BRET assay of Gαolf–D1 coupling for p.Gly213Ser, p.Ala353Thr, and the wild-type-behaving p.Ala311Thr","pmids":["24535567"],"confidence":"High","gaps":["Coupling measured only to D1, not A2A or other receptors","Heterologous system may not reflect striatal neuron context"]},{"year":2016,"claim":"Characterizing a partial loss-of-function variant with elevated basal signal and diminished dopamine-stimulated amplitude refined the spectrum of mechanistic defects beyond complete loss.","evidence":"BRET assay of dopamine-stimulated Gαolf signaling for p.F133L","pmids":["26810727"],"confidence":"Medium","gaps":["Single variant, single method","Consequence for downstream cAMP and neuronal output not measured"]},{"year":2017,"claim":"A heterozygous Gnal mouse model linked Gαolf deficiency to striatal cAMP signaling, motor and grooming phenotypes, and cholinergic-driven dystonia, localizing the disease mechanism to the striatum.","evidence":"Gnal+/- mice with behavioral, EEG, pharmacological (oxotremorine/muscarinic), and site-specific intrastriatal vs cerebellar infusion readouts","pmids":["28546310"],"confidence":"High","gaps":["Cell-type within striatum not resolved","Did not dissect D1- vs A2A-receptor contributions"]},{"year":2019,"claim":"Showing Gαolf deficiency intensifies D2-blockade responses with DNA breaks, altered histone phosphorylation/methylation, and cell death extended the phenotype to chromatin and cellular damage downstream of disrupted cAMP signaling.","evidence":"Gnal+/- mice with haloperidol challenge, γH2AX/comet assay, H3 phospho-Ser10 immunohistochemistry, methylation and chromatin fractionation","pmids":["31034808"],"confidence":"Medium","gaps":["Causal chain from cAMP loss to DNA damage not mechanistically established","Single lab"]},{"year":2024,"claim":"Defining the molecular reorganization of the A2AR/D2R–AC5–cAMP cascade in Gnal-deficient striatum pinpointed the receptor and effector components whose levels and function depend on Gαolf.","evidence":"Western blot of receptor/signaling proteins and patch-clamp of cholinergic interneurons in GNAL+/- rat striatum","pmids":["38182074"],"confidence":"High","gaps":["Whether protein-level changes are direct or compensatory not resolved","Mechanism linking Gαolf loss to D2R-partner downregulation unclear"]},{"year":2024,"claim":"Conditional striatal knockout demonstrated that loss of Gαolf in the striatum alone is sufficient to cause dystonia-like motor phenotypes and SPN hyperexcitability, establishing direct causality.","evidence":"Conditional Gnal fl/fl mice with Cre/AAV delivery, motor testing, and ex vivo patch-clamp of SPNs (preprint)","pmids":["39253490"],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Did not separate D1- from A2A-SPN contributions"]},{"year":2025,"claim":"Cell-type-specific deletion dissected the distinct behavioral consequences of Gαolf loss in D1- versus A2A-SPNs, resolving how a single subunit serves divergent striatal circuits via AC5 coupling.","evidence":"D1-SPN- and A2A-SPN-specific conditional Gnal knockout mice with motor testing, pharmacological challenges, and biochemical AC5 coupling analysis","pmids":["40902679"],"confidence":"High","gaps":["Molecular basis of the paradoxical caffeine response in A2A-SPN loss not defined","Relationship of these circuit phenotypes to human dystonia not established"]},{"year":null,"claim":"How Gαolf coupling defects mechanistically translate into the chromatin, DNA-damage, and circuit-level abnormalities, and how isoform/imprinting regulation shapes disease, remains open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model linking specific mutations to coupling loss","Causal pathway from cAMP signaling to DNA/chromatin changes unresolved","In vivo allele-specific expression and imprinting consequences not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,3,6,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,8]}],"localization":[],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,6,8]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,7,8]}],"complexes":[],"partners":["DRD1","DRD2","ADORA2A","ADCY5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P38405","full_name":"Guanine nucleotide-binding protein G(olf) subunit alpha","aliases":["Adenylate cyclase-stimulating G alpha protein, olfactory type"],"length_aa":381,"mass_kda":44.3,"function":"Guanine nucleotide-binding protein (G protein) involved as transducer in olfactory signal transduction controlled by G protein-coupled receptors (GPCRs) (By similarity). Contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (By similarity). Signaling by an activated GPCR promotes GDP release and GTP binding (By similarity). The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal (By similarity). Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (By similarity). GNAL/G(olf) alpha specifically mediates olfactory signal transduction within the olfactory neuroepithelium and the basal ganglia following GPCRs activation (By similarity). Acts by promoting the specific activation of adenylyl cyclase ADCY3, resulting in increased levels of the signaling molecule cAMP (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P38405/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNAL","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNAL","total_profiled":1310},"omim":[{"mim_id":"615073","title":"DYSTONIA 25; DYT25","url":"https://www.omim.org/entry/615073"},{"mim_id":"611900","title":"METALLOPHOSPHOESTERASE 1; MPPE1","url":"https://www.omim.org/entry/611900"},{"mim_id":"610142","title":"CENTROSOMAL PROTEIN, 290-KD; CEP290","url":"https://www.omim.org/entry/610142"},{"mim_id":"609147","title":"RIC8 GUANINE NUCLEOTIDE EXCHANGE FACTOR B; RIC8B","url":"https://www.omim.org/entry/609147"},{"mim_id":"606486","title":"CHARGED MULTIVESICULAR BODY PROTEIN 1B; CHMP1B","url":"https://www.omim.org/entry/606486"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":63.4}],"url":"https://www.proteinatlas.org/search/GNAL"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P38405","domains":[{"cath_id":"1.10.400.10","chopping":"71-185","consensus_level":"high","plddt":96.9475,"start":71,"end":185},{"cath_id":"3.40.50.300","chopping":"225-372","consensus_level":"high","plddt":94.7621,"start":225,"end":372}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P38405","model_url":"https://alphafold.ebi.ac.uk/files/AF-P38405-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P38405-F1-predicted_aligned_error_v6.png","plddt_mean":93.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNAL","jax_strain_url":"https://www.jax.org/strain/search?query=GNAL"},"sequence":{"accession":"P38405","fasta_url":"https://rest.uniprot.org/uniprotkb/P38405.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P38405/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P38405"}},"corpus_meta":[{"pmid":"23222958","id":"PMC_23222958","title":"Mutations in GNAL cause primary torsion dystonia.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23222958","citation_count":244,"is_preprint":false},{"pmid":"24535567","id":"PMC_24535567","title":"Mutations in GNAL: a novel cause of craniocervical dystonia.","date":"2014","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24535567","citation_count":65,"is_preprint":false},{"pmid":"24151159","id":"PMC_24151159","title":"Rare sequence variants in ANO3 and GNAL in a primary torsion dystonia series and controls.","date":"2013","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24151159","citation_count":42,"is_preprint":false},{"pmid":"16044173","id":"PMC_16044173","title":"Alternative transcripts and evidence of imprinting of GNAL on 18p11.2.","date":"2005","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16044173","citation_count":35,"is_preprint":false},{"pmid":"26725140","id":"PMC_26725140","title":"Novel GNAL mutation with intra-familial clinical heterogeneity: Expanding the phenotype.","date":"2015","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/26725140","citation_count":34,"is_preprint":false},{"pmid":"28546310","id":"PMC_28546310","title":"Heterozygous Gnal Mice Are a Novel Animal Model with Which to Study Dystonia Pathophysiology.","date":"2017","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28546310","citation_count":33,"is_preprint":false},{"pmid":"24500857","id":"PMC_24500857","title":"Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites.","date":"2014","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24500857","citation_count":30,"is_preprint":false},{"pmid":"11032382","id":"PMC_11032382","title":"Sequence and genomic organization of the human G-protein Golfalpha gene (GNAL) on chromosome 18p11, a susceptibility region for bipolar disorder and schizophrenia.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11032382","citation_count":28,"is_preprint":false},{"pmid":"8886169","id":"PMC_8886169","title":"Linkage disequilibrium analysis of G-olf alpha (GNAL) in bipolar affective disorder.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8886169","citation_count":25,"is_preprint":false},{"pmid":"27093447","id":"PMC_27093447","title":"GNAL mutation in isolated laryngeal dystonia.","date":"2016","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/27093447","citation_count":23,"is_preprint":false},{"pmid":"23759320","id":"PMC_23759320","title":"Mutation screening of GNAL gene in patients with primary dystonia from Northeast China.","date":"2013","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/23759320","citation_count":18,"is_preprint":false},{"pmid":"17166517","id":"PMC_17166517","title":"Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder.","date":"2006","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/17166517","citation_count":18,"is_preprint":false},{"pmid":"31158945","id":"PMC_31158945","title":"The Effect of Globus Pallidus Interna Deep Brain Stimulation on a Dystonia Patient with the GNAL Mutation Compared to Patients with DYT1 and DYT6.","date":"2019","source":"Journal of movement disorders","url":"https://pubmed.ncbi.nlm.nih.gov/31158945","citation_count":18,"is_preprint":false},{"pmid":"24408567","id":"PMC_24408567","title":"Screening of mutations in GNAL in sporadic dystonia patients.","date":"2014","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24408567","citation_count":15,"is_preprint":false},{"pmid":"24729450","id":"PMC_24729450","title":"De novo mutation in the GNAL gene causing seemingly sporadic dystonia in a Serbian patient.","date":"2014","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24729450","citation_count":12,"is_preprint":false},{"pmid":"31034808","id":"PMC_31034808","title":"Gnal haploinsufficiency causes genomic instability and increased sensitivity to haloperidol.","date":"2019","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31034808","citation_count":11,"is_preprint":false},{"pmid":"26810727","id":"PMC_26810727","title":"Screening of GNAL variants in Brazilian patients with isolated dystonia reveals a novel mutation with partial loss of function.","date":"2016","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26810727","citation_count":11,"is_preprint":false},{"pmid":"38182074","id":"PMC_38182074","title":"Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl cyclase/ cyclic AMP signaling pathway.","date":"2024","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/38182074","citation_count":9,"is_preprint":false},{"pmid":"15908736","id":"PMC_15908736","title":"G-protein Golfalpha (GNAL) is expressed in the vestibular end organs and primary afferent neurons of Rattus norvegicus.","date":"2005","source":"Journal of vestibular research : equilibrium & orientation","url":"https://pubmed.ncbi.nlm.nih.gov/15908736","citation_count":7,"is_preprint":false},{"pmid":"18842685","id":"PMC_18842685","title":"Wheels within wheels: clues to the evolution of the Gnas and Gnal loci.","date":"2008","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/18842685","citation_count":7,"is_preprint":false},{"pmid":"11474171","id":"PMC_11474171","title":"C18orf2, a novel, highly conserved intronless gene within intron 5 of the GNAL gene on chromosome 18p11.","date":"2001","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11474171","citation_count":5,"is_preprint":false},{"pmid":"33175450","id":"PMC_33175450","title":"Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review.","date":"2020","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33175450","citation_count":3,"is_preprint":false},{"pmid":"38686055","id":"PMC_38686055","title":"Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of GNAL in glioma.","date":"2024","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/38686055","citation_count":3,"is_preprint":false},{"pmid":"40902679","id":"PMC_40902679","title":"Characterization of mice with cell type-specific Gnal loss of function provides insights on GNAL-linked dystonia.","date":"2025","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/40902679","citation_count":2,"is_preprint":false},{"pmid":"39253490","id":"PMC_39253490","title":"Conditional Knockout of Striatal Gnal Produces Dystonia-like Motor Phenotypes.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39253490","citation_count":2,"is_preprint":false},{"pmid":"40909808","id":"PMC_40909808","title":"Mouse Gnal transcripts and transcriptomics in isolated dystonia.","date":"2025","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/40909808","citation_count":0,"is_preprint":false},{"pmid":"35396637","id":"PMC_35396637","title":"A new mutation in the GNAL gene in familial dystonia presenting with mental symptoms.","date":"2022","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35396637","citation_count":0,"is_preprint":false},{"pmid":"41632233","id":"PMC_41632233","title":"Long-term efficiency of pallidal DBS and the role of Levodopa treatment in DYT-GNAL and 18p deletion syndrome associated dystonia: an observational study and review of literature.","date":"2026","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/41632233","citation_count":0,"is_preprint":false},{"pmid":"41387123","id":"PMC_41387123","title":"The Gut Microbiota Regulates Motor Deficits via Butyrate in a Gnal+/- Mouse Model of DYT25 Dystonia.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41387123","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.02.662743","title":"Characterization of mice with cell type-specific  <i>Gnal</i>  loss of function provides insights on  <i>GNAL</i>  -linked dystonia","date":"2025-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.02.662743","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.20.665815","title":"Molecular unbalances between striosome and matrix compartments characterize the pathogenesis of Huntington’s disease model mouse","date":"2025-07-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.20.665815","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.13.648593","title":"Developmental, neuroanatomical and cellular expression of genes causing dystonia","date":"2025-04-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.13.648593","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.30.662485","title":"Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway","date":"2025-07-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.30.662485","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.02.24316741","title":"Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing","date":"2024-12-05","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.02.24316741","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.18.665513","title":"Transcriptional Circuitry in HGSOC: A Dynamic Three-State Model Informed by a Living Biobank of Purified Tumour Fractions","date":"2025-07-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.18.665513","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19688,"output_tokens":2710,"usd":0.049857,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10084,"output_tokens":3263,"usd":0.065998,"stage2_stop_reason":"end_turn"},"total_usd":0.115855,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"GNAL (encoding Gαolf) loss-of-function mutations (nonsense p.Ser293* and missense p.Val137Met, plus 6 additional mutations) cause primary torsion dystonia; impaired function of several mutants was demonstrated by BRET assays measuring Gαolf coupling activity.\",\n      \"method\": \"Exome sequencing, Sanger sequencing, bioluminescence resonance energy transfer (BRET) functional assay\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — BRET functional assay across multiple mutants, replicated across two families plus 6 additional mutations, published in high-impact peer-reviewed journal\",\n      \"pmids\": [\"23222958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GNAL missense mutations p.Gly213Ser and p.Ala353Thr impair Gαolf coupling to dopamine D1 receptors, as shown by BRET assay; variant p.Ala311Thr behaved like wild-type in the BRET assay (negative result for pathogenicity).\",\n      \"method\": \"Sanger sequencing, bioluminescence resonance energy transfer (BRET) assay measuring Gαolf–D1 receptor coupling\",\n      \"journal\": \"JAMA neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct functional BRET assay of mutant vs wild-type coupling, with built-in negative control (p.Ala311Thr), replicates approach of PMID:23222958\",\n      \"pmids\": [\"24535567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GNAL encodes two isoforms of Gαolf (a canonical and a longer alternative-first-exon isoform) that display different CNS expression patterns and both functionally couple to the dopamine D1 receptor when heterologously expressed in Sf9 cells; CpG islands near both first exons are differentially methylated, consistent with genomic imprinting.\",\n      \"method\": \"Identification of alternative transcript by 5′ RACE; heterologous expression in Sf9 cells for functional coupling; bisulfite/methylation analysis of CpG islands\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — heterologous expression functional coupling + methylation analysis, single lab, two orthogonal methods\",\n      \"pmids\": [\"16044173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Gαolf (encoded by GNAL) is enriched in striatal projection neurons where it mediates dopamine and adenosine signaling via the cAMP pathway; heterozygous Gnal knockout mice show altered self-grooming, motor coordination, spine morphology, and phospho-CaMKIIβ in the striatum, and develop dystonia-like movements after oxotremorine (cholinergic agonist) administration—prevented by M1 muscarinic antagonists and replicated by intrastriatal (but not cerebellar) oxotremorine infusion.\",\n      \"method\": \"Heterozygous Gnal+/- knockout mouse model; behavioral testing; EEG; pharmacological challenge (oxotremorine, telenzepine, pirenzepine, trihexyphenidyl, mecamylamine); intrastriatal vs. cerebellar drug infusion; striatal spine morphology and biochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO model with multiple orthogonal behavioral, pharmacological, and anatomical readouts; striatal specificity established by site-specific infusion\",\n      \"pmids\": [\"28546310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A novel GNAL variant p.F133L causes partial loss of Gαolf function: the mutant shows elevated basal BRET signal and severely diminished amplitude of dopamine-stimulated response, indicating impaired receptor-signal transduction.\",\n      \"method\": \"Sanger sequencing; BRET assay of Gαolf signaling in response to dopamine\",\n      \"journal\": \"Journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional BRET assay with quantitative readout, single lab, one method\",\n      \"pmids\": [\"26810727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Gαolf deficiency (Gnal+/- mice) intensifies responses to D2 receptor blockade (haloperidol), causing increased catalepsy, persistent DNA breaks, decreased cAMP-dependent histone H3 phosphorylation (Ser10), and increased cell death in the striatum; aged Gnal+/- mice show increased global DNA methylation, increased euchromatin, and dendritic structural abnormalities.\",\n      \"method\": \"Gnal+/- mouse model; haloperidol administration; behavioral testing (catalepsy); γH2AX/comet assay for DNA breaks; immunohistochemistry for H3 phospho-Ser10; global methylation assay; chromatin fractionation; dendritic morphology analysis\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical and histological readouts in genetic KO model, single lab\",\n      \"pmids\": [\"31034808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Loss of Gαolf (GNAL) in the striatum disrupts the A2AR/D2R–adenylyl cyclase–cAMP cascade: A2AR total levels increase, adenylyl cyclase 5 (AC5) decreases, D2R levels decrease along with its regulatory proteins RGS9-2, spinophilin, Gβ5, and β-arrestin2; D2R-mediated inhibitory effect on cholinergic interneurons is significantly attenuated in GNAL+/- rat striatum.\",\n      \"method\": \"Biochemical analysis (western blot) of receptor and signaling protein levels in GNAL+/- rat striatum; whole-cell patch-clamp electrophysiology of striatal cholinergic interneurons\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combined biochemical and electrophysiological approach in genetic rat model, multiple protein targets, single lab\",\n      \"pmids\": [\"38182074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Conditional striatal knockout of Gnal in mice produces overt dystonia-like motor phenotypes (hindlimb clasping, torticollis, motor incoordination) and increases excitability of striatal spiny projection neurons, establishing a direct causal link between striatal Gαolf loss and both behavioral dystonia and cellular hyperexcitability.\",\n      \"method\": \"Conditional Gnal fl/fl knockout mouse model; Cre delivery via genetics or AAV; motor behavioral testing; ex vivo whole-cell patch-clamp electrophysiology of striatal spiny projection neurons\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined cellular electrophysiological phenotype, preprint not yet peer-reviewed\",\n      \"pmids\": [\"39253490\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cell-type-specific conditional deletion of Gnal confirms Gαolf critically regulates adenylyl cyclase 5 (AC5) coupling to D1 and A2A receptors in striatal projection neurons: loss in D1-SPNs causes nocturnal hyperactivity and motor deficits; loss in A2A-SPNs causes striking spontaneous hyperactivity unresponsive to psychostimulants or A2A agonist, and paradoxically reduced by caffeine, revealing distinct functional roles of Gαolf downstream of each receptor class.\",\n      \"method\": \"Cell-type-specific conditional Gnal knockout mice (D1-SPN-specific and A2A-SPN-specific); motor behavioral testing; pharmacological challenges (cocaine, D-amphetamine, methylphenidate, KW6002, caffeine); biochemical analysis of AC5 coupling\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific genetic dissection with multiple behavioral and pharmacological readouts, peer-reviewed publication\",\n      \"pmids\": [\"40902679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The human GNAL gene spans >80 kb on chromosome 18p11, contains 12 coding exons, and is expressed as a single ~5.9 kb transcript in the brain; 5′ RACE identified an additional transcription initiation site; 3′ RACE confirmed functionality of the downstream polyadenylation signal.\",\n      \"method\": \"Genomic sequencing; 5′ and 3′ RACE; Northern blot\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct experimental characterization of gene structure by RACE and sequencing, single lab\",\n      \"pmids\": [\"11032382\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons and olfactory epithelium that forms a heterotrimeric complex (with β2γ7) to mediate stimulatory coupling of dopamine D1 and adenosine A2A receptors to adenylyl cyclase 5 (AC5), thereby driving cAMP production; loss-of-function mutations impair this receptor–AC coupling (demonstrated by BRET and electrophysiology), disrupt D2R/A2AR signaling cascades and striatal spiny projection neuron excitability, and cause isolated dystonia (DYT25), with cell-type-specific deletion experiments showing distinct roles of Gαolf downstream of D1-SPNs (motor coordination) versus A2A-SPNs (locomotor tone).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons that couples dopamine and adenosine receptors to the adenylyl cyclase–cAMP pathway [#3]. Gαolf functionally couples to the dopamine D1 receptor and transduces dopamine-stimulated signaling, an activity quantifiable by BRET [#1, #4]. In the striatum, Gαolf loss disrupts the A2AR/D2R–adenylyl cyclase 5 (AC5) cascade: A2AR levels rise while AC5, D2R, and its regulatory partners RGS9-2, spinophilin, G β5, and β-arrestin2 fall, and D2R-mediated inhibition of cholinergic interneurons is attenuated [#6]. Cell-type-specific deletion establishes that Gαolf regulates AC5 coupling to both D1 and A2A receptors, with loss in D1-SPNs producing motor deficits and loss in A2A-SPNs producing spontaneous hyperactivity, revealing distinct roles downstream of each receptor class [#8]. Loss-of-function mutations in GNAL cause isolated/primary torsion dystonia (DYT25), and striatal or conditional Gnal deletion reproduces dystonia-like motor phenotypes alongside increased spiny projection neuron excitability [#0, #7]. The gene produces alternative transcripts from differentially methylated first-exon promoters consistent with genomic imprinting [#2].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing the genomic architecture of human GNAL was a prerequisite for interpreting later disease variants and isoform usage.\",\n      \"evidence\": \"Genomic sequencing, 5′/3′ RACE, and Northern blot of the chromosome 18p11 locus\",\n      \"pmids\": [\"11032382\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not address protein function\", \"Did not resolve the tissue distribution of distinct isoforms\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying two Gαolf isoforms with differential CNS expression and demonstrating both couple to the D1 receptor connected gene structure to signaling output and raised imprinting as a regulatory layer.\",\n      \"evidence\": \"5′ RACE, heterologous expression in Sf9 cells for D1 coupling, and bisulfite methylation analysis\",\n      \"pmids\": [\"16044173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Imprinting inferred from methylation, not allele-specific expression in vivo\", \"Functional distinction between isoforms not resolved\", \"Single-lab heterologous system\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linking GNAL loss-of-function mutations to primary torsion dystonia and showing impaired coupling activity established GNAL as a dystonia gene with a measurable molecular defect.\",\n      \"evidence\": \"Exome/Sanger sequencing in two families plus additional mutations, with BRET coupling assays of mutants\",\n      \"pmids\": [\"23222958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which receptor–effector step each mutation disrupts in neurons\", \"No structural mechanism of how mutations impair coupling\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that specific missense mutants impair Gαolf–D1 receptor coupling while a control variant behaved as wild-type provided a functional assay to discriminate pathogenic from benign variants.\",\n      \"evidence\": \"BRET assay of Gαolf–D1 coupling for p.Gly213Ser, p.Ala353Thr, and the wild-type-behaving p.Ala311Thr\",\n      \"pmids\": [\"24535567\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coupling measured only to D1, not A2A or other receptors\", \"Heterologous system may not reflect striatal neuron context\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Characterizing a partial loss-of-function variant with elevated basal signal and diminished dopamine-stimulated amplitude refined the spectrum of mechanistic defects beyond complete loss.\",\n      \"evidence\": \"BRET assay of dopamine-stimulated Gαolf signaling for p.F133L\",\n      \"pmids\": [\"26810727\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant, single method\", \"Consequence for downstream cAMP and neuronal output not measured\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"A heterozygous Gnal mouse model linked Gαolf deficiency to striatal cAMP signaling, motor and grooming phenotypes, and cholinergic-driven dystonia, localizing the disease mechanism to the striatum.\",\n      \"evidence\": \"Gnal+/- mice with behavioral, EEG, pharmacological (oxotremorine/muscarinic), and site-specific intrastriatal vs cerebellar infusion readouts\",\n      \"pmids\": [\"28546310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type within striatum not resolved\", \"Did not dissect D1- vs A2A-receptor contributions\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing Gαolf deficiency intensifies D2-blockade responses with DNA breaks, altered histone phosphorylation/methylation, and cell death extended the phenotype to chromatin and cellular damage downstream of disrupted cAMP signaling.\",\n      \"evidence\": \"Gnal+/- mice with haloperidol challenge, γH2AX/comet assay, H3 phospho-Ser10 immunohistochemistry, methylation and chromatin fractionation\",\n      \"pmids\": [\"31034808\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from cAMP loss to DNA damage not mechanistically established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defining the molecular reorganization of the A2AR/D2R–AC5–cAMP cascade in Gnal-deficient striatum pinpointed the receptor and effector components whose levels and function depend on Gαolf.\",\n      \"evidence\": \"Western blot of receptor/signaling proteins and patch-clamp of cholinergic interneurons in GNAL+/- rat striatum\",\n      \"pmids\": [\"38182074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether protein-level changes are direct or compensatory not resolved\", \"Mechanism linking Gαolf loss to D2R-partner downregulation unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Conditional striatal knockout demonstrated that loss of Gαolf in the striatum alone is sufficient to cause dystonia-like motor phenotypes and SPN hyperexcitability, establishing direct causality.\",\n      \"evidence\": \"Conditional Gnal fl/fl mice with Cre/AAV delivery, motor testing, and ex vivo patch-clamp of SPNs (preprint)\",\n      \"pmids\": [\"39253490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Did not separate D1- from A2A-SPN contributions\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cell-type-specific deletion dissected the distinct behavioral consequences of Gαolf loss in D1- versus A2A-SPNs, resolving how a single subunit serves divergent striatal circuits via AC5 coupling.\",\n      \"evidence\": \"D1-SPN- and A2A-SPN-specific conditional Gnal knockout mice with motor testing, pharmacological challenges, and biochemical AC5 coupling analysis\",\n      \"pmids\": [\"40902679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the paradoxical caffeine response in A2A-SPN loss not defined\", \"Relationship of these circuit phenotypes to human dystonia not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How Gαolf coupling defects mechanistically translate into the chromatin, DNA-damage, and circuit-level abnormalities, and how isoform/imprinting regulation shapes disease, remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model linking specific mutations to coupling loss\", \"Causal pathway from cAMP signaling to DNA/chromatin changes unresolved\", \"In vivo allele-specific expression and imprinting consequences not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 3, 6, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 6, 8]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 7, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"DRD1\", \"DRD2\", \"ADORA2A\", \"ADCY5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}